Reaction Details |
| Report a problem with these data |
Target | Cytochrome P450 2D6 |
---|
Ligand | BDBM50177530 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_334181 (CHEMBL866475) |
---|
IC50 | 2000±n/a nM |
---|
Citation | Berlin, M; Ting, PC; Vaccaro, WD; Aslanian, R; McCormick, KD; Lee, JF; Albanese, MM; Mutahi, MW; Piwinski, JJ; Shih, NY; Duguma, L; Solomon, DM; Zhou, W; Sher, R; Favreau, L; Bryant, M; Korfmacher, WA; Nardo, C; West, RE; Anthes, JC; Williams, SM; Wu, RL; Susan She, H; Rivelli, MA; Corboz, MR; Hey, JA Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists. Bioorg Med Chem Lett16:989-94 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 2D6 |
---|
Name: | Cytochrome P450 2D6 |
Synonyms: | CP2D6_HUMAN | CYP2D6 | CYP2DL1 | CYPIID6 | Cytochrome P450 2D6 (CYP2D6) | Debrisoquine 4-hydroxylase | P450-DB1 |
Type: | Protein |
Mol. Mass.: | 55774.82 |
Organism: | Homo sapiens (Human) |
Description: | P10635 |
Residue: | 497 |
Sequence: | MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ
LRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF
LARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK
AVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV
LRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA
DLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI
HEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF
LDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV
FAFLVSPSPYELCAVPR
|
|
|
BDBM50177530 |
---|
n/a |
---|
Name | BDBM50177530 |
Synonyms: | 4-((1H-imidazol-4-yl)methyl)-1-(3-(3-(cyclohexyloxy)phenoxy)propyl)piperidine | CHEMBL380139 |
Type | Small organic molecule |
Emp. Form. | C24H35N3O2 |
Mol. Mass. | 397.5536 |
SMILES | C(COc1cccc(OC2CCCCC2)c1)CN1CCC(Cc2cnc[nH]2)CC1 |
Structure |
|